US Patent 11083776 Protoxin-II variants and methods of use

Patent 11083776 was granted and assigned to Janssen Biotech on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Janssen Biotech

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110837760

Patent Inventor Names

Ross Fellows0

Mack Flinspach0

Qinghao Xu0

Alan Wickenden0

Andrew Piekarz0

Date of Patent

August 10, 2021

Patent Application Number

201911040

Date Filed

November 4, 2019

Patent abstract

The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11083776 Protoxin-II variants and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API